The article contains information for entities seeking accreditation to become qualified suppliers that furnish home infusion therapy (HIT) services in coordination with the furnishing of home infusion drugs administered through an item of durable medical equipment (DME) beginning in calendar year 2021.
HIT services may be a mixed bag for providers. While the new benefit offers a way to break into the home infusion market, many analysts feel that reimbursement is not in line with the actual cost of providing these services.
Click here to read the MLN Matters article. For a general overview of the new HIT services, click here to read CMS’ press release from October.